All Opportunities

Confidential Project

Project Iris

A U.S. royalty opportunity of up to 10% on net sales of the first generic version of THC, a complex biologic used in chronic autoimmune disorders.

Geography
United States
Royalty
Up to 10%
Launch
Targeted Q1 2028
IP Horizon
Through 2040+
Project Iris — Investment Teaser Open in New Tab Download

Loading the teaser… if it does not appear, use “Open in New Tab” or “Download” above.

Strictly confidential · Prepared by Intelligentzia Capital Management · Scroll within the frame to navigate pages

Discuss This Project

Explore Project Iris

Contact our team to receive additional information under NDA.